{
    "Trade/Device Name(s)": [
        "TriVerity",
        "TriVerity Test",
        "TriVerity Test System"
    ],
    "Submitter Information": "Inflammatix, Inc.",
    "510(k) Number": "K241676",
    "Predicate Device Reference 510(k) Number(s)": [
        "K203748"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PRE",
        "OOI"
    ],
    "Summary Letter Date": "December 9, 2024",
    "Summary Letter Received Date": "December 9, 2024",
    "Submission Date": "June 10, 2024",
    "Regulation Number(s)": [
        "21 CFR 866.3215"
    ],
    "Regulation Name(s)": [
        "Device To Detect And Measure Non-Microbial Analyte(s) In Human Clinical Specimens To Aid In Assessment Of Patients With Suspected Sepsis"
    ],
    "Analyte Class(es)": [
        "genetic molecular",
        "microbiology"
    ],
    "Analyte(s)": [
        "ANKRD22",
        "ARG1",
        "BATF",
        "C3AR1",
        "CD163",
        "CEACAM1",
        "CLEC5A",
        "CTSL1",
        "DEFA4",
        "HERC5",
        "HLA-DMB",
        "IFI27",
        "IFI44",
        "IFI44L",
        "IL18R1",
        "IL1R2",
        "ISG15",
        "JUP",
        "KCNJ2",
        "LY86",
        "OASL",
        "OLFM4",
        "PSMB9",
        "RSAD2",
        "S100A12",
        "TDRD9",
        "TGFBI",
        "XAF1",
        "ZDHHC19",
        "KPNA6",
        "RREB1",
        "YWHAB"
    ],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [
        "PAXgene Blood RNA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Myrna instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Reverse transcription loop-mediated isothermal amplification (RT-LAMP)",
        "Automated gene expression assay",
        "Fluorescence detection"
    ],
    "Methodologies": [
        "Gene expression profiling",
        "qRT-LAMP",
        "Molecular expression testing"
    ],
    "Submission Type(s)": [
        "Test",
        "System",
        "Cartridge",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for TriVerity genetic molecular test using qRT-LAMP on the Myrna instrument for host response transcript profiling to aid in differentiation of bacterial, viral, and non-infectious illness and prediction of illness severity in suspected sepsis.",
    "Indications for Use Summary": "Automated in vitro diagnostic test measuring host response gene expression from RNA isolated from whole blood in PAXgene Blood RNA tube via RT-LAMP on the Myrna instrument, used in conjunction with clinical assessment to differentiate bacterial, viral, and non-infectious illness and to predict 7-day need for mechanical ventilation, vasopressors, and/or renal replacement therapy in adults presenting to the emergency department with suspected acute infection or sepsis.",
    "fda_folder": "Microbiology"
}